. 2003 Jul;41(7):3046–3050. doi: 10.1128/JCM.41.7.3046-3050.2003

TABLE 3.

Comparison of HCV RNA levels in serum before (T0) and at the end of therapy (T6) and in liver (T0) among HIV-HCV-coinfected patients with or without a virological end-of-treatment response

Patient group (n)	HCV RNA^a level in:
	Serum (IU/ml) at:			Liver (IU/μg) at T0^d
	T0^b	T3^c	T6	Liver (IU/μg) at T0^d
Patients with a virological response (7)	523,252	<615	<615	192,737
Patients with no virological response (6)	1,465,203	35,645	149,319	666,355

P values were calculated by using the Mann-Whitney U test. The OR value is that of the no-virological-response patients relative to an increase of 20,000 IU of HCV RNA.

P = 0.25; OR = 1.01; 95% CI = 0.99 to 1.04.

P = 0.01.

P = 0.03; OR = 1.10; 95 CI = 0.99 to 1.22.